Effectiveness of adalimumab for refractory serpiginous choroiditis

Ocul Immunol Inflamm. 2014 Oct;22(5):405-8. doi: 10.3109/09273948.2013.859276. Epub 2013 Dec 4.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adalimumab
  • Adult
  • Anti-Inflammatory Agents / therapeutic use
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Choroiditis / diagnosis
  • Choroiditis / drug therapy*
  • Fluorescein Angiography
  • Fundus Oculi
  • Humans
  • Male
  • Multifocal Choroiditis
  • Tomography, Optical Coherence
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal, Humanized
  • Tumor Necrosis Factor-alpha
  • Adalimumab